You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Business & Finance
NYU Langone Study Correlates Poorer Socioeconomic Status with Lower Survival in Patients with Anal Cancer
14 March 2018 - - According to a new study led by investigators at New York, New York-based academic medical center NYU Langone Health's Perlmutter Cancer Center, both overall survival and anal cancer cancer specific survival can be predicted by median household income (MHI) after controlling for additional factors like age, sex, race, and stage of cancer, the center said.
Investigators found chance of death increased by about 30% for those living in areas of poverty.
MHI had the strongest association with both overall survival and, specifically, survival from anal cancer. Other secondary predictors of lower survival from anal cancer include gender (men are more vulnerable), older age, African-American race, unmarried status, and, time of diagnosis.
The data included a total of 9,550 study participants. MHI, age, sex, race, marital status, stage and grade of cancer, year of diagnosis, and radiation-treatment status were recorded.
NYU Langone Medical Center is an academic medical center affiliated with New York University. The center is dedicated to patient care, education, and research.
Investigators found chance of death increased by about 30% for those living in areas of poverty.
MHI had the strongest association with both overall survival and, specifically, survival from anal cancer. Other secondary predictors of lower survival from anal cancer include gender (men are more vulnerable), older age, African-American race, unmarried status, and, time of diagnosis.
The data included a total of 9,550 study participants. MHI, age, sex, race, marital status, stage and grade of cancer, year of diagnosis, and radiation-treatment status were recorded.
NYU Langone Medical Center is an academic medical center affiliated with New York University. The center is dedicated to patient care, education, and research.
Login
Related Headlines
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access